Analysis of CRO Benchmark Report in Global Industry : Trends, Demand and Technology 2017
ResearchMoz presents professional and in-depth study of "PharmaLeaders: CRO Benchmark Report - Financial Performance Benchmarking & Competitive Landscape Assessment of Leading CROs".
The CRO Benchmark Report applies GlobalDatas proprietary ranking methodology to compare the competitive positions of 11 leading CRO companies on 17 financial metrics. These companies are analyzed based on financial performance, cost-containment, capital structure and firm utilization to illustrate the different strategies these companies are using to increase value for their shareholders. Throughout the report, GlobalDatas Industry Dynamics Team provides you with expert insight, expanding on each of the metrics discussed. In addition to the financial metrics, this report discusses trends impacting the CRO marketplace, along with partnering and acquisition activity, and operations strategy. This report also provides drill-down analyses of three service lines and four geographies examining each of these segments revenue and growth leaders, and business development strategies. Lastly, this report provides GlobalDatas outlook on the CRO sector and each companys future competitive position.
Highlights
About the Report
The CRO market is highly fragmented comprised of some 1,000 individual companies, most of which are privately owned. These companies vary significantly in size and breadth of services from a four person bioanalysis research lab in Thailand to companies like Quintiles and Covance which have tens of thousands of employees in over 100 countries across the globe. GlobalData identified 11 CROs to apply its benchmarking methodology providing a foundation for strategic discussion and analysis. GlobalDatas coverage examines these CROs from a unique company-centric lens combining financial performance and resources allocation with partnering activity and regional developments to assess a companys overall strategy. This type of coverage is unlike any other analysis available, and delivers a consistent view into the evolution of these companies corporate growth. We also covered some 30 other privately-held CROs to give our analysis more specificity and granularity.
Get PDF for more Professional and Technical insights @ http://www.researchmoz.us/enquiry.php?type=S&repid=173553
Key Questions Answered
What specific strategies are these CROs employing to gain market share?
What drivers accounted for the revenue growth for the company over the past year?
Which trends will affect the CRO marketplace over the next few years?
What particular services or capabilities are my competitors developing?
Who are the revenue and growth leaders in each service line and geography?
What specific business development activities are taking place, in terms of partnerships or M&A?
How are CROs growing their physical infrastructures and human resources to better serve the needs of their customers?
What region-specific operations and capabilities are CROs adding to gain share in emerging markets?
Scope
Analysis of the key drivers and trends shaping the global CRO market; including biologics manufacturing, emerging markets, and eClinical technologies
A deep dive into the synergies behind partnering and acquisition activity
Discussion of business line and regional segment strategies
Assessments of company financials by revenue, margin, expense and capital structure
Firm utilization, resources management, and efficiency metrics
Leadership/management changes
Make an Enquiry about TOC @ http://www.researchmoz.us/enquiry.php?type=E&repid=173553
Reasons to buy
Analyze and track the strategies that these CROs are using to gain share in the increasingly competitive market
Understand the underlying financial metrics that differentiate certain companies from the pack in terms of growth and profitability, spending and asset structure
Organize your sales and marketing strategy to identify companies with proprietary technologies to maximize opportunities for strategic investment or partnerships
Use this information as an independent source for your due diligence and transaction strategy
Table of Contents
1 Table of Contents 7
1.1 List of Tables 14
1.2 List of Figures 14
2 Introduction 17
2.1 Report Scope 17
2.1.1 GlobalData Selection Criteria 18
2.1.2 Companies Financially Benchmarked 18
2.1.3 Other Companies Covered 18
2.2 Upcoming Reports 19
2.3 Recently Published Reports 19
2.4 GlobalDatas Benchmarking Methodology 20
2.5 GlobalData CRO Benchmark Leader: EPS Corporation 20
Browse Report @ http://www.researchmoz.us/pharmaleaders-cro-benchmark-report-financial-performance-benchmarking-and-competitive-landscape-assessment-of-leading-cros-report.html
3 CRO Market Dynamics 22
3.1 Outsourcing Service Delivery Models 22
3.1.1 Fully Integrated Service Model 22
3.1.2 Functional Service Model 23
3.1.3 The Bottom Line: Use a Hybrid Approach 24
3.2 Quintiles Goes Public 24
3.2.1 Quintiles IPO Raises $947M, Pricing an Increased Number of Shares at Top Range 24
3.3 Weak Demand for Preclinical Services Causes CROs to Economize 25
3.4 CROs Are Transitioning into Becoming Experts in Biologics Manufacturing 26
3.4.1 WuXi Will Become a Leader in Biologics Manufacturing through its Multi-pronged Strategy 27
For More Information Kindly Contact:
ResearchMoz
Mr. Nachiket Ghumare,
90 State Street, Albany NY, United States - 12207
Tel: +1-518-621-2074
USA-Canada Toll Free: 866-997-4948
Email: sales@researchmoz.us
Follow us on LinkedIn @ http://bit.ly/1TBmnVG
Follow me on : https://marketinfo247.wordpress.com/
The CRO Benchmark Report applies GlobalDatas proprietary ranking methodology to compare the competitive positions of 11 leading CRO companies on 17 financial metrics. These companies are analyzed based on financial performance, cost-containment, capital structure and firm utilization to illustrate the different strategies these companies are using to increase value for their shareholders. Throughout the report, GlobalDatas Industry Dynamics Team provides you with expert insight, expanding on each of the metrics discussed. In addition to the financial metrics, this report discusses trends impacting the CRO marketplace, along with partnering and acquisition activity, and operations strategy. This report also provides drill-down analyses of three service lines and four geographies examining each of these segments revenue and growth leaders, and business development strategies. Lastly, this report provides GlobalDatas outlook on the CRO sector and each companys future competitive position.
Highlights
About the Report
The CRO market is highly fragmented comprised of some 1,000 individual companies, most of which are privately owned. These companies vary significantly in size and breadth of services from a four person bioanalysis research lab in Thailand to companies like Quintiles and Covance which have tens of thousands of employees in over 100 countries across the globe. GlobalData identified 11 CROs to apply its benchmarking methodology providing a foundation for strategic discussion and analysis. GlobalDatas coverage examines these CROs from a unique company-centric lens combining financial performance and resources allocation with partnering activity and regional developments to assess a companys overall strategy. This type of coverage is unlike any other analysis available, and delivers a consistent view into the evolution of these companies corporate growth. We also covered some 30 other privately-held CROs to give our analysis more specificity and granularity.
Get PDF for more Professional and Technical insights @ http://www.researchmoz.us/enquiry.php?type=S&repid=173553
Key Questions Answered
What specific strategies are these CROs employing to gain market share?
What drivers accounted for the revenue growth for the company over the past year?
Which trends will affect the CRO marketplace over the next few years?
What particular services or capabilities are my competitors developing?
Who are the revenue and growth leaders in each service line and geography?
What specific business development activities are taking place, in terms of partnerships or M&A?
How are CROs growing their physical infrastructures and human resources to better serve the needs of their customers?
What region-specific operations and capabilities are CROs adding to gain share in emerging markets?
Scope
Analysis of the key drivers and trends shaping the global CRO market; including biologics manufacturing, emerging markets, and eClinical technologies
A deep dive into the synergies behind partnering and acquisition activity
Discussion of business line and regional segment strategies
Assessments of company financials by revenue, margin, expense and capital structure
Firm utilization, resources management, and efficiency metrics
Leadership/management changes
Make an Enquiry about TOC @ http://www.researchmoz.us/enquiry.php?type=E&repid=173553
Reasons to buy
Analyze and track the strategies that these CROs are using to gain share in the increasingly competitive market
Understand the underlying financial metrics that differentiate certain companies from the pack in terms of growth and profitability, spending and asset structure
Organize your sales and marketing strategy to identify companies with proprietary technologies to maximize opportunities for strategic investment or partnerships
Use this information as an independent source for your due diligence and transaction strategy
Table of Contents
1 Table of Contents 7
1.1 List of Tables 14
1.2 List of Figures 14
2 Introduction 17
2.1 Report Scope 17
2.1.1 GlobalData Selection Criteria 18
2.1.2 Companies Financially Benchmarked 18
2.1.3 Other Companies Covered 18
2.2 Upcoming Reports 19
2.3 Recently Published Reports 19
2.4 GlobalDatas Benchmarking Methodology 20
2.5 GlobalData CRO Benchmark Leader: EPS Corporation 20
Browse Report @ http://www.researchmoz.us/pharmaleaders-cro-benchmark-report-financial-performance-benchmarking-and-competitive-landscape-assessment-of-leading-cros-report.html
3 CRO Market Dynamics 22
3.1 Outsourcing Service Delivery Models 22
3.1.1 Fully Integrated Service Model 22
3.1.2 Functional Service Model 23
3.1.3 The Bottom Line: Use a Hybrid Approach 24
3.2 Quintiles Goes Public 24
3.2.1 Quintiles IPO Raises $947M, Pricing an Increased Number of Shares at Top Range 24
3.3 Weak Demand for Preclinical Services Causes CROs to Economize 25
3.4 CROs Are Transitioning into Becoming Experts in Biologics Manufacturing 26
3.4.1 WuXi Will Become a Leader in Biologics Manufacturing through its Multi-pronged Strategy 27
For More Information Kindly Contact:
ResearchMoz
Mr. Nachiket Ghumare,
90 State Street, Albany NY, United States - 12207
Tel: +1-518-621-2074
USA-Canada Toll Free: 866-997-4948
Email: sales@researchmoz.us
Follow us on LinkedIn @ http://bit.ly/1TBmnVG
Follow me on : https://marketinfo247.wordpress.com/
Comments
Post a Comment